[Targeted destruction of lymphomas with the aid of radioimmunotherapy. Tumor antibodies isotope taxi].
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D002614:Chelating Agents; D006801:Humans; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000532:radiotherapy*; D008224:Lymphoma, Follicular / Q000276:immunology / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000379:methods*; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D002614:Chelating Agents; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan
Mithilfe der Radioimmuntherapie werden Lymphome gezielt zerstört. Tumor-Antikörper als Isotopen-Taxi.